Adherence to subcutaneous biologic treatment for inflammatory bowel disease. Ramos L, Ramos-Rodriguez J, Barreda R, Gutierrez-Nicolas F, et al. Gastroenterol Hepatol 2022;45:335-341.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramos L, Ramos-Rodriguez J, Barreda R, Gutierrez-Nicolas F, et al. Adherence to subcutaneous biologic treatment for inflammatory bowel disease. Gastroenterol Hepatol 2022;45:335-341.
PMID: 34051312